Gene: GTPBP10
Official Full Name: GTP binding protein 10provided by HGNC
Gene Summary: Small G proteins, such as GTPBP10, act as molecular switches that play crucial roles in the regulation of fundamental cellular processes such as protein synthesis, nuclear transport, membrane trafficking, and signal transduction (Hirano et al., 2006 [PubMed 17054726]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24160 | GTPBP10 Knockout cell line (HeLa) | Human | GTPBP10 | 1:3~1:6 | Negative | Online Inquiry |
KO24161 | GTPBP10 Knockout cell line (HCT 116) | Human | GTPBP10 | 1:2~1:4 | Negative | Online Inquiry |
KO24162 | GTPBP10 Knockout cell line (HEK293) | Human | GTPBP10 | 1:3~1:6 | Negative | Online Inquiry |
KO24163 | GTPBP10 Knockout cell line (A549) | Human | GTPBP10 | 1:3~1:4 | Negative | Online Inquiry |
GTPBP10 Gene Knockout Cell Lines are genetically engineered cell lines specifically developed to facilitate the study of the GTPBP10 gene—an essential component in various cellular processes including protein synthesis, cell growth, and stress responses. These knockout models have been meticulously crafted using CRISPR-Cas9 technology to introduce targeted deletions, allowing researchers to investigate the functional role of GTPBP10 in cellular mechanisms more precisely. By removing this gene, the GTPBP10 knockout cell lines serve as powerful tools to elucidate pathways that GTPBP10 is involved in, as well as to assess the phenotypic consequences of its absence.
The primary function of these cell lines lies in their ability to mimic pathological states that can arise from GTPBP10 dysregulation, rendering them valuable for studies ranging from cancer biology to neurodegenerative diseases. Researchers can utilize these models to screen for pharmacological agents, assess gene therapies, or elucidate molecular interactions that involve GTPBP10. Their utility in both basic and applied research contexts significantly enhances our understanding of cellular biology and opens avenues for novel therapeutic development.
What sets GTPBP10 Gene Knockout Cell Lines apart from other genetic models is their precise editing and high stability, which ensures reproducibility and reliability across experiments. Furthermore, their customization potential enables researchers to engineer additional parameters such as drug resistance markers or fluorescent reporters, amplifying their versatility.
For researchers and clinicians, these knockout cell lines offer a streamlined approach to dissect intricate biological questions, making it easier to translate findings into potential clinical applications. Our company's commitment to scientific excellence is evident in the rigorous validation and characterization of these GTPBP10 knockout models, ensuring that they meet the highest standards of quality and performance. By leveraging our expertise in genetic engineering and cell biology, we provide researchers with the tools necessary to drive innovation and discovery in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.